Pages that link to "Q37168725"
Jump to navigation
Jump to search
The following pages link to Metformin transport by a newly cloned proton-stimulated organic cation transporter (plasma membrane monoamine transporter) expressed in human intestine (Q37168725):
Displaying 50 items.
- Clinical Pharmacokinetics of Metformin (Q22241422) (← links)
- Metformin: An Old Drug for the Treatment of Diabetes but a New Drug for the Protection of the Endothelium (Q26999344) (← links)
- Metformin and the gastrointestinal tract (Q28079250) (← links)
- Personalized medicine in Type 2 Diabetes (Q28542708) (← links)
- Equilibrative nucleoside transporters-A review (Q30244329) (← links)
- The role of variants regulating metformin transport and action in women with polycystic ovary syndrome (Q30275579) (← links)
- Individualized therapy for type 2 diabetes: clinical implications of pharmacogenetic data (Q30571118) (← links)
- Variants in Pharmacokinetic Transporters and Glycemic Response to Metformin: A Metgen Meta-Analysis. (Q33658321) (← links)
- Pharmacokinetics of metformin during pregnancy (Q33861891) (← links)
- An update on the pharmacogenomics of metformin: progress, problems and potential (Q34003050) (← links)
- Uptake of pramipexole by human organic cation transporters (Q34037009) (← links)
- Adenosine transport by plasma membrane monoamine transporter: reinvestigation and comparison with organic cations (Q34211096) (← links)
- Taste of a pill: organic cation transporter-3 (OCT3) mediates metformin accumulation and secretion in salivary glands (Q34245062) (← links)
- Tyrosine 112 Is Essential for Organic Cation Transport by the Plasma Membrane Monoamine Transporter (Q34367791) (← links)
- Colorectal and Prostate Cancer Risk in Diabetes: Metformin, an Actor behind the Scene (Q34438700) (← links)
- Metformin--mode of action and clinical implications for diabetes and cancer (Q34658712) (← links)
- Podocyte-specific expression of organic cation transporter PMAT: implication in puromycin aminonucleoside nephrotoxicity (Q34974839) (← links)
- Effect of gastric bypass surgery on the absorption and bioavailability of metformin. (Q35043256) (← links)
- Molecular analysis and structure-activity relationship modeling of the substrate/inhibitor interaction site of plasma membrane monoamine transporter. (Q35429797) (← links)
- Association of Organic Cation Transporter 1 With Intolerance to Metformin in Type 2 Diabetes: A GoDARTS Study. (Q35675566) (← links)
- Enhancing the intestinal absorption of molecules containing the polar guanidino functionality: a double-targeted prodrug approach (Q35831312) (← links)
- Few Drugs Display Flip-Flop Pharmacokinetics and These Are Primarily Associated with Classes 3 and 4 of the BDDCS (Q35952140) (← links)
- Electrophysiological characterization of the polyspecific organic cation transporter plasma membrane monoamine transporter (Q35996455) (← links)
- Residue Ile89 in human plasma membrane monoamine transporter influences its organic cation transport activity and sensitivity to inhibition by dilazep (Q36024314) (← links)
- Potent and Selective Inhibition of Plasma Membrane Monoamine Transporter by HIV Protease Inhibitors (Q36186145) (← links)
- Expression Profiling of Solute Carrier Gene Families at the Blood-CSF Barrier (Q36186589) (← links)
- Effect of concomitant administration of trospium chloride extended release on the steady-state pharmacokinetics of metformin in healthy adults (Q36579750) (← links)
- The Effect of Nizatidine, a MATE2K Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of Metformin in Healthy Volunteers (Q36689589) (← links)
- Metformin Is a Substrate and Inhibitor of the Human Thiamine Transporter, THTR-2 (SLC19A3). (Q36709745) (← links)
- Metformin pathways: pharmacokinetics and pharmacodynamics (Q36836472) (← links)
- The effect of dipyridamole on the pharmacokinetics of metformin: a randomized crossover study in healthy volunteers. (Q36908331) (← links)
- The Effect of Famotidine, a MATE1-Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of Metformin (Q36924379) (← links)
- Polymorphism in human organic cation transporters and metformin action (Q37126649) (← links)
- A marriage of two "Methusalem" drugs for the treatment of psoriasis?: Arguments for a pilot trial with metformin as add-on for methotrexate. (Q37170305) (← links)
- Ischemia/Reperfusion-inducible protein modulates the function of organic cation transporter 1 and multidrug and toxin extrusion 1. (Q37171418) (← links)
- Reduced-function SLC22A1 polymorphisms encoding organic cation transporter 1 and glycemic response to metformin: a GoDARTS study (Q37193773) (← links)
- A simplified PBPK modeling approach for prediction of pharmacokinetics of four primarily renally excreted and CYP3A metabolized compounds during pregnancy (Q37207844) (← links)
- Effect of gestational age on mRNA and protein expression of polyspecific organic cation transporters during pregnancy (Q37325586) (← links)
- Renoprotective Effects of Metformin are Independent of Organic Cation Transporters 1 &2 and AMP-activated Protein Kinase in the Kidney (Q37366972) (← links)
- Trimethoprim-metformin interaction and its genetic modulation by OCT2 and MATE1 transporters (Q37369333) (← links)
- Pharmacogenetics in diabetes (Q37424309) (← links)
- Hyperglycaemia-induced resistance to Docetaxel is negated by metformin: a role for IGFBP-2. (Q37428521) (← links)
- Pharmacogenetics and personalized treatment of type 2 diabetes (Q37508445) (← links)
- The role of transporters in the pharmacokinetics of orally administered drugs (Q37537018) (← links)
- Involvement of organic cation transporter 3 (Oct3/Slc22a3) in the bioavailability and pharmacokinetics of antidiabetic metformin in mice (Q37656702) (← links)
- Mechanistic enhancement of the intestinal absorption of drugs containing the polar guanidino functionality (Q37828505) (← links)
- Disposition of metformin: Variability due to polymorphisms of organic cation transporters (Q37848844) (← links)
- Overview of metformin: special focus on metformin extended release (Q38024861) (← links)
- A Comprehensive Review of Drug-Drug Interactions with Metformin (Q38460322) (← links)
- A prospective analysis of co-processed non-ionic surfactants in enhancing permeability of a model hydrophilic drug (Q38554851) (← links)